Advances in bioprocessing over the last couple of decades have resulted in an increasingly complex and diverse biopharma market with new opportunities to treat unmet medical needs. What strategies should your company consider for recruiting, training, and retaining qualified candidates in order to remain competitive in a burgeoning biopharma market?
Overcoming the challenges of manufacturing and administering a complex product to any patient is critical for delivering cell therapies. Here, two industry experts provide practical advice on strategies to meet supply chain challenges.
New modalities, such as bispecific antibodies, present unique challenges compared to monoclonal antibody (mAb) production. For purification there’s not just one right answer regarding which strategy to use. Here are some industry insights to help you navigate the bispecific jungle.